Seoul says J&J vaccine supply not from troubled Baltimore factory
Johnson & Johnson's Janssen COVID-19 vaccine / AFP-Yonhap
The Johnson & Johnson Janssen COVID-19 vaccine supplied to South Korea was not produced in a troubled Baltimore plant that was forced to throw out about 60 million doses due to possible contamination, the health ministry said Saturday.
The health authorities have been administering the Janssen single-shot vaccine since Thursday to reserve forces, civil defense members and others in charge of defense and foreign affairs after the U.S. government donated 1 million doses to the Korean armed forces.
A total of 453,732 people received the single-dose COVID-19 vaccine in the first two days of vaccinations, according to the Korea Disease Control and Prevention Agency (KDCA). Those aged 30 and below are not eligible for the vaccine due to concerns over rare blood clots.
As concerns grow over the Janssen vaccine following media reports over its safety, the health authorities said the vaccine doses administered here were not from the troubled Baltimore manufacturer, and they were authorized for use after passing Ministry of Food and Drug Safety tests upon arrival.
"Among the 1 million Janssen doses donated by the U.S., there were none manufactured in the Baltimore factory," the health ministry's central disaster response team said. "(Janssen) vaccine bottles delivered to the nation are considered not contaminated."
According to media reports, the U.S. Food and Drug Administration told Johnson & Johnson to dispose of up to 60 million doses of the COVID-19 vaccine produced at the Baltimore plant due to possible contamination.
The New York Times report noted the Baltimore plant has been shut down for about two months and the vaccines in question were produced before this. (Yonhap)